Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Recent Advances in Pulmonary Hypertension
Author(s): Akshyaya Pradhan , Richa Tyagi , Prachi Sharma , et al Added: 6 months ago

Heart Failure

Prevention & Chronic Conditions
AHA 23: KABUKI: DOAC in Pts with CTEPH
Author(s): Kazuya Hosokawa , Abe Kotaro Added: 1 year ago
AHA 2023 — Dr Kazuya Hosokawa and Dr Abe Kotaro (Kyushu University Hospital, JP) join us to share the findings of the KABUKI trial (NCT04730037). The aim of KABUKI (Daiichi Sankyo) is to assess whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).This investigator-initiated, multicenter, phase 3… View more

Prevention & Chronic Conditions
Viewpoint on Arterial Hypertension
Author(s): Maria Lorenza Muiesan Added: 3 months ago

Prevention & Chronic Conditions
Research Area(s) / Expertise: Job title: Director of the National Pulmonary Hypertension Service
Shao-Liang Chen
Dr Shao-Liang Chen is an interventional cardiologist at theNanjing First Hospital, Nanjing Medical University, Jiangsu Province, Nanjing, China. Dr Chen has published over 300 papers in peer-reviewed journals. Dr Chen's research interests include coronary intervention, pulmonary arterial hypertension and biological molecular science. Dr Shao-Liang Chen is Section Editor of European… View more
Research Area(s) / Expertise: Job title: Head of the Paediatric Cardiology Unit
ACC 25 Late-Breaking Discussion: The ADVANCE-HTN Trial
Author(s): Harriette Van Spall , Luke Laffin Added: 3 months ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial… View more

Prevention & Chronic Conditions
Job title: Assistant Professor of Medicine in the Division of Cardiology and Director of the Pulmonary Vascular Diseases Program
Myung H Park, MD, FACC, is an Assistant Professor of Medicine in the Division of Cardiology and Director of the Pulmonary Vascular Diseases Program at the University of Maryland School of Medicine. She is a member of the American College of Cardiology, the Heart Failure Society of America, the International Society of Heart and Lung Transplantation, and the Pulmonary Hypertension Association… View more
Resistant Hypertension: An Overview
Author(s): Giacomo Buso , Claudia Agabiti-Rosei , Matteo Lemoli , et al Added: 1 year ago

Prevention & Chronic Conditions
ECG Exercise Stress Test in Coronary Artery Disease
Author(s): Gaetano Antonio Lanza Added: 1 month ago

Guidelines & Statements